EP Plenary session - EU transparency in the development, purchase and distribution of COVID-19 vaccines

The Committee on the Environment, Public Health and Food Safety (ENVI) discuss the state of play on assessing and authorising vaccines against COVID-19 with Emer COOKE, Executive Director of the European Medicines Agency (EMA), in the European Parliament in Brussels.

State of play on the assessment and authorization of vaccines against COVID-19: extracts from the debate

During the remote plenary session (23-26/11/2020) of the European Parliament in Brussels, MEPs debate on the state of play on Covid-19 vaccines with Ursula VON DER LEYEN, President of the EC and the German Presidency ahead of the 10-11 December EU summit.

Preparation of the European Council meeting of 10-11 December 2020: extracts from the debate on the state of play on Covid-19 vaccines

MEPS from the Committee on the Environment, Public Health and Food Safety (ENVI) and from the Committee on Industry, Research and Energy (ITRE) hold a public hearing with researchers and representatives from pharmaceutical companies and civil society organisations on how to secure access to COVID-19 vaccines for all, including challenges linked to clinical trials, production and distribution in the European Parliament in Brussels.

How to secure access to COVID-19 vaccines for EU citizens; clinical trials, production and distribution challenges: extracts from the joint public hearing

Public Hearing of Members of the Committee on the Environment, Public Health and Food Safety and the EP Committee on Industry, Research and Energy with Thomas TRIOMPHE, Executive Vice President, Sanofi Pasteur, Jean STEPHENNE, Chairman of the Supervisory Board, accompanied by Pierre Kemula, Chief Financial Officer, CureVac, Fergus SWEENEY, Head of Clinical Studies and Manufacturing Task Force, European Medicines Agency, Professor Robin SHATTOCK, Faculty of Medicine, Department of Infectious Disease, Imperial College London, Dr Sidney WONG, Director, Médecins Sans Frontières Access Campaign, Magdalena RODRIGUEZ de AZERO, Executive Director, Vaccines Europe, European Federation of Pharmaceutical Industries and Associations. Conclusion and closing remarks by Pascal CANFIN (Renew, FR), ENVI Chair and by Cristian-Silviu BUŞOI (EPP, RO), ITRE Chair.

Public Hearing on How to secure access to COVID-19 vaccines for EU citizens: clinical trials, production and distribution challenges. Joint EP Committee ENVI and ITRE. Conclusion and closing remarks by the Chairs

Public Hearing of Members of the Committee on the Environment, Public Health and Food Safety and the EP Committee on Industry, Research and Energy with Thomas TRIOMPHE, Executive Vice President, Sanofi Pasteur, Jean STEPHENNE, Chairman of the Supervisory Board, accompanied by Pierre Kemula, Chief Financial Officer, CureVac, Fergus SWEENEY, Head of Clinical Studies and Manufacturing Task Force, European Medicines Agency, Professor Robin SHATTOCK, Faculty of Medicine, Department of Infectious Disease, Imperial College London, Dr Sidney WONG, Director, Médecins Sans Frontières Access Campaign, Magdalena RODRIGUEZ de AZERO, Executive Director, Vaccines Europe, European Federation of Pharmaceutical Industries and Associations. Welcome and opening remarks by Pascal CANFIN (Renew,FR), ENVI Chair and by Cristian-Silviu BUŞOI (EPP,RO), ITRE Chair. This transcription speech is the result of an automatic process. Check against delivery.

Public Hearing on How to secure access to COVID-19 vaccines for EU citizens: clinical trials, production and distribution challenges. Joint EP Committee ENVI and ITRE. Welcome and opening remarks by the Chairs

Public Hearing of Members of the Committee on the Environment, Public Health and Food Safety and the EP Committee on Industry, Research and Energy with Thomas TRIOMPHE, Executive Vice President, Sanofi Pasteur, Jean STEPHENNE, Chairman of the Supervisory Board, accompanied by Pierre Kemula, Chief Financial Officer, CureVac, Fergus SWEENEY, Head of Clinical Studies and Manufacturing Task Force, European Medicines Agency, Professor Robin SHATTOCK, Faculty of Medicine, Department of Infectious Disease, Imperial College London, Dr Sidney WONG, Director, Médecins Sans Frontières Access Campaign, Magdalena RODRIGUEZ de AZERO, Executive Director, Vaccines Europe, European Federation of Pharmaceutical Industries and Associations. Part 2 of 2 Q&A with ENVI and ITRE Members.

Public Hearing on How to secure access to COVID-19 vaccines for EU citizens: clinical trials, production and distribution challenges. Joint EP Committee ENVI and ITRE. 2/ 2 Q&A with ENVI and ITRE Members.

Public Hearing of Members of the Committee on the Environment, Public Health and Food Safety and the EP Committee on Industry, Research and Energy with Thomas TRIOMPHE, Executive Vice President, Sanofi Pasteur, Jean STEPHENNE, Chairman of the Supervisory Board, accompanied by Pierre Kemula, Chief Financial Officer, CureVac, Fergus SWEENEY, Head of Clinical Studies and Manufacturing Task Force, European Medicines Agency, Professor Robin SHATTOCK, Faculty of Medicine, Department of Infectious Disease, Imperial College London, Dr Sidney WONG, Director, Médecins Sans Frontières Access Campaign, Magdalena RODRIGUEZ de AZERO, Executive Director, Vaccines Europe, European Federation of Pharmaceutical Industries and Associations. Part 1 of 2 Q&A with ENVI and ITRE Members.

Public Hearing on How to secure access to COVID-19 vaccines for EU citizens: clinical trials, production and distribution challenges. Joint EP Committee ENVI and ITRE. 1/2 Q&A with ENVI and ITRE Members.

Public Hearing of Members of the Committee on the Environment, Public Health and Food Safety and the EP Committee on Industry, Research and Energy with Thomas TRIOMPHE, Executive Vice President, Sanofi Pasteur, Jean STEPHENNE, Chairman of the Supervisory Board, accompanied by Pierre Kemula, Chief Financial Officer, CureVac, Fergus SWEENEY, Head of Clinical Studies and Manufacturing Task Force, European Medicines Agency, Professor Robin SHATTOCK, Faculty of Medicine, Department of Infectious Disease, Imperial College London, Dr Sidney WONG, Director, Médecins Sans Frontières Access Campaign, Magdalena RODRIGUEZ de AZERO, Executive Director, Vaccines Europe, European Federation of Pharmaceutical Industries and Associations. Presentation by the speakers. This transcription speech is the result of an automatic process. Check against delivery.

Public Hearing on How to secure access to COVID-19 vaccines for EU citizens: clinical trials, production and distribution challenges. Joint EP Committee ENVI and ITRE. Presentation by the speakers.

Following a presentation by the Commission on the status of COVID-19 vaccines, the Committee on Environment and Public Health (ENVI) debate with Sandra GALLINA, Deputy Director General of Health and Food safety (European Commission) on how to ensure equitable access to affordable and safe COVID-19 vaccines everywhere, for everyone who needs them, in the Europena Parliament in Brussels.

EU vaccines strategy: extracts from the debate

The Committee on the Environment, Public Health and Food Safety (ENVI) debates with Stella KYRIAKIDES, European Commissioner for Health and Food Safety, on an EU Strategy for COVID-19 vaccines. It proposes a joint EU approach to accelerate the development of vaccines, in the European Parliament in Brussels.

EU Strategy for COVID-19 vaccines: extracts from the exchange of views with Stella KYRIAKIDES, European Commissioner for Health and Food Safety

During the plenary session of the European Parliament in Brussels, MEPs debate with Council and Commission on boosting research to ensure everyone has swift access to future vaccines and treatments for the novel Coronavirus, Covid-19.

Vaccines and therapeutics in the context of Covid-19: extracts from the debate

During the plenary session in the European Parliament in Brussels (13-16 May 2020), debate on vaccines and therapeutics in the context of Covid-19 (corona). Links related to this program Opening statements by Nikolina BRNJAC, Croatian Presidency and by Margaritis SCHINAS, Vice-President of the European Commission in charge of promoting our European Way of Life.

Vaccines and therapeutics in the context of Covid-19: Opening statements by Council and Commission

During the plenary session in the European Parliament in Brussels (13-16 May 2020), debate on vaccines and therapeutics in the context of Covid-19. First round political group leaders

Vaccines and therapeutics in the context of Covid-19: First round political group leaders

This stockshot provides illustration footage of laboratories in Sweden, Denmark and Ireland working on finding a vaccine against Covid-19 (Coronavirus outbreak) with co-funding from the EU.

Infoclip: Covid-19 - EU-funded Research on Covid-19 Vaccine

During the EP plenary session (16-19 April 2018) in Strasbourg, MEPs discuss and vote on vaccine hesitancy and drop in vaccination rates in Europe. Statements by Elena GENTILE (S&D, IT) and Vytenis ANDRIUKAITIS, Member of the EC in charge of Health and Food Safety. Illustrative pictures

Vaccine hesitancy and drop in vaccination rates in Europe: extracts from the debate (18/04), extracts from the vote and illustrative pictures

This infoclip illustrates vaccination for babies : medical examination and vaccines given as an injection in the upper arm or the thigh. Differents vaccines are stocked in a fridge.

Infoclip: Vaccines in the EU

During the meeting of the Committee on the Environment, Public Health and Food Safety (ENVI) in the EP in Brussels, MEPs call for measures to address vaccine “hesitancy” in the EU, where growing numbers of people are choosing to delay or refuse vaccines. Recent data from EU member states show a significant drop in the use of vaccines. The results are: 55 in favour, 1 against and 3 abstentions. Statements by Marco AFFRONTE (Greens/EFA, IT), Elena GENTILE (S&D, IT) and Renate SOMMER (EPP, DE), co-Rapporteurs.

Vaccine hesitancy and drop in vaccination rates in Europe: extracts from the vote, statements by co-Rapporteurs and illustrative shots

Parlament razmatra reformu tržišta plina i ispituje porast neodlučnosti pri cijepljenju u EU. Zastupnici također sagledavaju zaštitu prava žrtava terorizma.

652 rezultata

EP Plenary session - EU transparency in the development, purchase and distribution of COVID-19 vaccines

EP Plenary session - EU transparency in the development, purchase and distribution of COVID-19 vaccines

EP Plenary session - EU transparency in the development, purchase and distribution of COVID-19 vaccines

EP Plenary session - EU transparency in the development, purchase and distribution of COVID-19 vaccines

EP Plenary session - EU transparency in the development, purchase and distribution of COVID-19 vaccines

EP Plenary session - EU transparency in the development, purchase and distribution of COVID-19 vaccines

EP Plenary session - EU transparency in the development, purchase and distribution of COVID-19 vaccines

EP Plenary session - EU transparency in the development, purchase and distribution of COVID-19 vaccines

EP Plenary session - EU transparency in the development, purchase and distribution of COVID-19 vaccines

EP Plenary session - EU transparency in the development, purchase and distribution of COVID-19 vaccines

EP Plenary session - EU transparency in the development, purchase and distribution of COVID-19 vaccines

EP Plenary session - EU transparency in the development, purchase and distribution of COVID-19 vaccines

EP Plenary session - EU transparency in the development, purchase and distribution of COVID-19 vaccines

EP Plenary session - EU transparency in the development, purchase and distribution of COVID-19 vaccines

EP Plenary session - EU transparency in the development, purchase and distribution of COVID-19 vaccines

EP Plenary session - EU transparency in the development, purchase and distribution of COVID-19 vaccines

EP Plenary session - EU transparency in the development, purchase and distribution of COVID-19 vaccines

EP Plenary session - EU transparency in the development, purchase and distribution of COVID-19 vaccines